Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris

Background/Objectives: Psoriasis is an inflammatory skin disease, which is associated with metabolic syndrome and insulin resistance. Irisin is an adipokine and myokine that regulates the metabolic status during times of increased insulin sensitivity. In this study, we aimed to investigate changes i...

Full description

Bibliographic Details
Main Authors: Emine Tugba Alatas, Mehmet Kalayci, Asude Kara, Gursoy Dogan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-03-01
Series:Dermatologica Sinica
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1027811716300593
_version_ 1818020893016719360
author Emine Tugba Alatas
Mehmet Kalayci
Asude Kara
Gursoy Dogan
author_facet Emine Tugba Alatas
Mehmet Kalayci
Asude Kara
Gursoy Dogan
author_sort Emine Tugba Alatas
collection DOAJ
description Background/Objectives: Psoriasis is an inflammatory skin disease, which is associated with metabolic syndrome and insulin resistance. Irisin is an adipokine and myokine that regulates the metabolic status during times of increased insulin sensitivity. In this study, we aimed to investigate changes in the serum level of irisin in psoriasis patients in comparison with participants who did not have any disease (control group). We hope the results of our study would also aid in establishing a protocol aimed at understanding the etiopathogenesis and treatment of psoriasis. Materials and methods: The study included 30 patients with psoriasis vulgaris, who presented to the dermatology outpatient clinic and were not receiving systemic treatment. The control group included voluntary participants who did not have any disease (n = 30). In addition to venous and salivary irisin levels, glucose, triglyceride, cholesterol, high-density lipoprotein, and low-density lipoprotein levels, and Homeostasis Model Assessment of Insulin Resistance scores were measured in both control and patient groups. Results: Serum irisin and salivary irisin levels were significantly lower in the patient group compared with the control group (p < 0.05). In the patient group, serum irisin levels had a positive correlation with salivary irisin levels (r = 418; p = 0.022) and a negative correlation with Psoriasis Area and Severity Index (r = −437, p = 0.016) and Dermatological Life Quality Index (r = −424; p = 0.02) scores. Conclusion: This is the first study evaluating irisin levels in patients with psoriasis vulgaris in the literature. The results of our study show that serum and salivary irisin levels were significantly lower in the patient group when compared with the control group. Irisin levels in patients with severe psoriasis were low, suggesting that irisin may have a role in the pathogenesis of psoriasis and may be a marker showing the severity of psoriasis, which could warn us against the development of insulin resistance and diabetes mellitus.
first_indexed 2024-04-14T08:11:37Z
format Article
id doaj.art-3bb3c6fd780c4a5f819c71bdffc90444
institution Directory Open Access Journal
issn 1027-8117
language English
last_indexed 2024-04-14T08:11:37Z
publishDate 2017-03-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Dermatologica Sinica
spelling doaj.art-3bb3c6fd780c4a5f819c71bdffc904442022-12-22T02:04:32ZengWolters Kluwer Medknow PublicationsDermatologica Sinica1027-81172017-03-01351121510.1016/j.dsi.2016.08.004Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgarisEmine Tugba Alatas0Mehmet Kalayci1Asude Kara2Gursoy Dogan3Department of Dermatology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, TurkeyDepartment of Biochemistry Elazig Training and Research Hospital, Elazıg, TurkeyDepartment of Dermatology, Mugla Sitki Kocman University Training and Research Hospital, Mugla, TurkeyDepartment of Dermatology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, TurkeyBackground/Objectives: Psoriasis is an inflammatory skin disease, which is associated with metabolic syndrome and insulin resistance. Irisin is an adipokine and myokine that regulates the metabolic status during times of increased insulin sensitivity. In this study, we aimed to investigate changes in the serum level of irisin in psoriasis patients in comparison with participants who did not have any disease (control group). We hope the results of our study would also aid in establishing a protocol aimed at understanding the etiopathogenesis and treatment of psoriasis. Materials and methods: The study included 30 patients with psoriasis vulgaris, who presented to the dermatology outpatient clinic and were not receiving systemic treatment. The control group included voluntary participants who did not have any disease (n = 30). In addition to venous and salivary irisin levels, glucose, triglyceride, cholesterol, high-density lipoprotein, and low-density lipoprotein levels, and Homeostasis Model Assessment of Insulin Resistance scores were measured in both control and patient groups. Results: Serum irisin and salivary irisin levels were significantly lower in the patient group compared with the control group (p < 0.05). In the patient group, serum irisin levels had a positive correlation with salivary irisin levels (r = 418; p = 0.022) and a negative correlation with Psoriasis Area and Severity Index (r = −437, p = 0.016) and Dermatological Life Quality Index (r = −424; p = 0.02) scores. Conclusion: This is the first study evaluating irisin levels in patients with psoriasis vulgaris in the literature. The results of our study show that serum and salivary irisin levels were significantly lower in the patient group when compared with the control group. Irisin levels in patients with severe psoriasis were low, suggesting that irisin may have a role in the pathogenesis of psoriasis and may be a marker showing the severity of psoriasis, which could warn us against the development of insulin resistance and diabetes mellitus.http://www.sciencedirect.com/science/article/pii/S1027811716300593insulin resistanceirisinpsoriasis vulgaris
spellingShingle Emine Tugba Alatas
Mehmet Kalayci
Asude Kara
Gursoy Dogan
Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris
Dermatologica Sinica
insulin resistance
irisin
psoriasis vulgaris
title Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris
title_full Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris
title_fullStr Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris
title_full_unstemmed Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris
title_short Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris
title_sort association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris
topic insulin resistance
irisin
psoriasis vulgaris
url http://www.sciencedirect.com/science/article/pii/S1027811716300593
work_keys_str_mv AT eminetugbaalatas associationbetweeninsulinresistanceandserumandsalivaryirisinlevelsinpatientswithpsoriasisvulgaris
AT mehmetkalayci associationbetweeninsulinresistanceandserumandsalivaryirisinlevelsinpatientswithpsoriasisvulgaris
AT asudekara associationbetweeninsulinresistanceandserumandsalivaryirisinlevelsinpatientswithpsoriasisvulgaris
AT gursoydogan associationbetweeninsulinresistanceandserumandsalivaryirisinlevelsinpatientswithpsoriasisvulgaris